Login

Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Onsdag 15 Januari | 13:03:08 Europe / Stockholm

Svenska | English

2024-10-21 13:45:00

Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.

Number of contributors: 5 (all of which have been updated or confirmed before the report)

KPI (MSEK, unless otherwise specified)	Q3 2024E
Net sales	208
Organic growth in local currency (%)	37.2
Gross profit	155
EBITDA	41
EBIT	23
Net profit	21
Earnings per share (SEK)	0.69
Net sales per segment:
Thoracic	136
Abdominal	47
Services	24

XVIVO Perfusion’s Q3 report will be released on Thursday, 24 October, at 07:30 CEST.